Senior Principal
M VenturesCheck size: M Ventures does not publish a standard current check-size range on its official site.
Emma Johnson invests or supports investments through M Ventures's published strategy: Invest strategically in companies at the intersection of science and technology, including biotech, life-science tools, electronics and sustainability.
Scientific and technical breakthroughs with strong teams, defensibility and potential strategic relevance to Merck's businesses.
Opportunities without a material science or technology component or strategic fit are less aligned with the published mandate.
Explain the breakthrough, validation, intellectual property, market, strategic relevance and the milestones new capital would fund.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Emma Johnson is a current Senior Principal at M Ventures, according to the firm's official roster. No additional background is inferred where the firm does not publish a biography.